Question 1

Does Franklin Templeton own RCKT stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Franklin Templeton holds 10,166 shares of RCKT (Rocket Pharmaceuticals), worth $34,768.

Question 2

How many shares of RCKT does Franklin Templeton own?

Accepted Answer

As of its Q2 2026 13F, Franklin Templeton holds 10,166 shares of RCKT (Rocket Pharmaceuticals).

Question 3

What is Franklin Templeton's RCKT position worth?

Accepted Answer

As of its Q2 2026 13F, Franklin Templeton's RCKT position is worth $34,768.

Question 4

Is Franklin Templeton buying or selling RCKT?

Accepted Answer

In Q2 2026, Franklin Templeton reduced its RCKT position by 929 shares (-8.4%).

Question 5

When did Franklin Templeton first buy RCKT?

Accepted Answer

Franklin Templeton already held RCKT in its Q3 2019 13F, the earliest on record, and has listed it in 26 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	10,166	-8.4%	$34,768	0.0%	$3.42	0
2026-Q1	Increased	11,095	+2.3%	$39,720	0.0%	$3.58	14
2025-Q4	New	10,848	—	$38,076	0.0%	$3.51	31
2025-Q2	Exited	0	-100.0%	$0	0.0%	$2.45	0
2025-Q1	Increased	870,308	+33.2%	$5.8M	0.0%	$6.67	35
2024-Q4	Decreased	653,559	-62.2%	$8.2M	0.0%	$12.57	0
2024-Q3	Decreased	1.7M	-7.7%	$29.2M	0.0%	$18.47	0